Volume 20 (2006): Issue 4 (Apr 2006)
in Neurosurgical Focus
-
Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001Pages: E1Publication Date: Apr 2006
-
Recurrent glioblastoma multiforme: a review of natural history and management optionsPages: E3Publication Date: Apr 2006
-
Management of malignant glioma: steady progress with multimodal approachesPages: E3Publication Date: Apr 2006
-
The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapyPages: E11Publication Date: Apr 2006
-
Convection-enhanced delivery of therapeutics for brain disease, and its optimizationPages: E12Publication Date: Apr 2006
-
Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomasPages: E13Publication Date: Apr 2006
-
Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodiesPages: E14Publication Date: Apr 2006
-
Image-guided resection of high-grade glioma: patient selection factors and outcomePages: E16Publication Date: Apr 2006
-
Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericinPages: E20Publication Date: Apr 2006
-
Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapyPages: E21Publication Date: Apr 2006
-
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiformePages: E22Publication Date: Apr 2006
-
Efficacy of antiangiogenic targeted toxins against glioblastoma multiformePages: E23Publication Date: Apr 2006
-
Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measuresPages: E24Publication Date: Apr 2006
© 1944-2019 American Association of Neurological Surgeons
Powered by: